AMN Healthcare Services, Inc. · NYSE (us_market)
Healthcare · Medical Care Facilities · United States
AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-03-05$22.54 RISE2026-04-10$17.87 PEAK2026-05-13$30.87 69d | -20.7% 36d | Missed | Missed | — | — | +72.7% 33d | Missed |
DROP2026-02-02$21.73 RISE2026-02-13$16.25 PEAK2026-05-11$30.27 98d | -25.2% 11d | Missed | Missed | — | — | +86.3% 87d | Missed |
DROP2025-10-24$21.17 RISE2026-01-05$15.10 PEAK2026-03-05$22.54 132d | -28.7% 73d | Missed | Missed | — | — | +49.3% 59d | Missed |
DROP2025-10-24$21.17 RISE2025-11-20$15.34 PEAK2026-02-02$21.73 101d | -27.5% 27d | Missed | Missed | — | — | +41.7% 74d | Missed |
DROP2025-05-20$22.94 RISE2025-09-25$17.91 PEAK2025-10-24$21.17 157d | -21.9% 128d | Missed | Missed | — | — | +18.2% 29d | Missed |
DROP2025-04-01$23.80 RISE2025-08-11$16.49 PEAK2025-10-24$21.17 206d | -30.7% 132d | Missed | Missed | — | — | +28.4% 74d | Missed |
DROP2025-01-30$28.10 RISE2025-04-21$17.79 PEAK2025-05-20$22.94 110d | -36.7% 81d | Missed | Missed | — | — | +28.9% 29d | Missed |
DROP2024-10-17$42.42 RISE2025-02-18$23.07 PEAK2025-02-21$27.58 127d | -45.6% 124d | Missed | Missed | — | — | +19.5% 3d | Missed |
DROP2024-08-23$53.37 RISE2024-12-20$22.94 PEAK2025-01-30$28.10 160d | -57.0% 119d | Missed | Missed | — | — | +22.5% 41d | Missed |
DROP2024-07-30$68.05 RISE2024-11-15$23.70 PEAK2025-01-30$28.10 184d | -65.2% 108d | Missed | Missed | — | — | +18.6% 76d | Missed |
DROP2024-03-21$66.65 RISE2024-07-10$47.02 PEAK2024-07-30$68.05 131d | -29.5% 111d | Missed | Missed | — | — | +44.7% 20d | Missed |
DROP2024-02-12$79.13 RISE2024-02-23$54.85 PEAK2024-03-21$66.65 38d | -30.7% 11d | Missed | Missed | — | — | +21.5% 27d | Missed |
DROP2023-07-20$111.69 RISE2023-11-13$58.17 PEAK2024-01-09$78.50 173d | -47.9% 116d | Missed | Missed | — | — | +34.9% 57d | Missed |
DROP2022-11-22$124.52 RISE2023-03-30$81.77 PEAK2023-06-13$109.34 203d | -34.3% 128d | Missed | Missed | — | — | +33.7% 75d | Missed |
DROP2022-07-20$123.81 RISE2022-09-01$100.85 PEAK2022-11-01$127.04 104d | -18.5% 43d | Missed | Missed | — | — | +26.0% 61d | Missed |
1–15 / 21 1 / 2 | |||||||
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BERLIN, May 27 () - The head of Airbus Defence ruled out the complete failure of the crisis-hit Franco-German FCAS fighter jet project, saying at least a networking system for weapons and drone programme would go ahead. • Plans to develop the air combat system risk collapse due to a dispute over control between France's Dassault Aviation and Airbus, which represents Germany and Spain in the €100-billion ($116 billion) project • Airbus Defence chief Michael Schoellhorn said on Wednesday he
VORTEX-S spaceplane alliance puts Dassault Aviation société anonyme (ENXTPA:AM) in the ESA spotlight Dassault Aviation société anonyme (ENXTPA:AM) is in focus after announcing a new alliance with OHB to propose the VORTEX-S multipurpose spaceplane project to the European Space Agency. The project would see Dassault Aviation act as prime architect and integrator of the spaceplane, with OHB leading the service module, as both companies work with additional European partners on future space...
Investors need to pay close attention to AMN stock based on the movements in the options market lately.
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AMN Healthcare Services’ first quarter was marked by rapid scaling to support several large labor disruption events, a factor management described as a major operational milestone. CEO Caroline Grace credited the company’s technology investments and clinician network for enabling AMN to respond quickly and deliver high-touch service during these disruptions. She emphasized, “Our ability to move thousands of clinicians to meet urgent needs delivered great value on a scale we could not have done j
AMN Healthcare Services (AMN) drew fresh attention after reporting first quarter 2026 results that exceeded market expectations, along with updated guidance and a strong stock move, prompting many investors to reassess the shares. See our latest analysis for AMN Healthcare Services. The Q1 earnings beat, new guidance and Eric Palmer’s board appointment have come alongside a sharp swing in sentiment, with the stock showing a 61.34% 1 month share price return and a 100.40% year to date share...
2026-05-14. The following slide deck was published by AMN Healthcare Services, Inc.
More than 1,500 stocks have reported earnings since the current season began, and the average stock that's reported has seen an average absolute one-day share price reaction of roughly 7%.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
AMN Healthcare Services, Inc. (AMN) Bank of America Global Healthcare Conference 2026 May 13, 2026 6:40 PM EDTCompany ParticipantsCaroline Grace -...
Presentation Operator MessageOperator Right. I want to thank everyone for joining us. It's my pleasure to be hosting this discussion with AMN Healthcare. With us today, we have Cary Grace, who's
AMN Healthcare Services, Inc. (AMN) Q1 2026 Earnings Call May 7, 2026 5:00 PM EDTCompany ParticipantsRandle Reece - Senior Director of Investor Relations...
UBS analyst A.J. Rice maintains AMN Healthcare Services (NYSE:AMN) with a Neutral and raises the price target from $19.5 to $32.
DALLAS, May 13, 2026 -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Directors, effective...
Healthcare staffing company AMN Healthcare Services (NYSE:AMN) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 99.9% year on year to $1.38 billion. On the other hand, next quarter’s revenue guidance of $627.5 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.10 per share was 29.9% above analysts’ consensus estimates.
AMN Q1 beat was fueled by labor disruption revenue; core sales were flat and Q2 guide signals a sharp drop. Click here to read my latest analysis.
BMO Capital analyst Jeffrey Silber maintains AMN Healthcare Services (NYSE:AMN) with a Outperform and raises the price target from $25 to $26.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| AMN | +37.17% | +42.01% | +83.82% | +37.23% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +34.20% | +47.72% | +87.26% | +24.55% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | 0.19 | — | — |
| 2026-05-07 | 1.62 | 2.10 | +29.87% |
| 2026-02-19 | 0.27 | 0.22 | -17.86% |
| 2025-11-06 | 0.20 | 0.39 | +95.20% |
| 2025-08-07 | 0.19 | 0.30 | +60.90% |
| 2025-05-08 | 0.21 | 0.45 | +119.32% |
| 2025-02-20 | 0.49 | 0.75 | +53.67% |
| 2024-11-07 | 0.57 | 0.61 | +6.29% |
| 2024-08-08 | 0.78 | 0.98 | +26.02% |
| 2024-05-09 | 0.96 | 0.97 | +1.37% |
| 2024-02-15 | 1.25 | 1.32 | +5.41% |
| 2023-11-02 | 1.63 | 1.97 | +20.54% |
| 2023-08-03 | 2.15 | 2.38 | +10.96% |
| 2023-05-04 | 2.36 | 2.49 | +5.56% |
| 2023-02-16 | 2.19 | 2.48 | +13.31% |
| 2022-11-03 | 2.40 | 2.57 | +6.92% |